In a research note today, JF Apex Securities said the group, which aims to establish 17 hospitals and 3,300 new beds over the next five years, is well poised to sustain its growing momentum and penetrate the fast growing market of the Central and Eastern Europe, Middle East and North Africa.
The research house also expects IHH Healthcare’s profit margin to be lifted by the economies of scale pursuant to its aggressive expansion, as well as higher profitability from higher-end market.
The group has secured 22 cornerstone investors, with Lembaga Tabung Haji and AIA Group Ltd among the established names.
“We expect the involvement of these established cornerstone investors would boost the public confidence in the group’s initial public offering,” the research house said.
Meanwhile, it also viewed the International Medical University, IHH Healthcare’s wholly-owned subsidiary, as an incubator for the group’s human resource procurement and intensive medical research.
“The group has acquired 43.9% market share in Singapore as of the last financial year; furthermore, we expect the opening of the new Mount Elizabeth Novena Hospital would consolidate its top position there.
“We expect to see a strong trading interest in the stock for the short term, because of the defensive nature of the healthcare sector under the current market uncertainty,” it said.
JF Apex Securities placed a fair value of RM3 for IHH Healthcare.